Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Empire Vending Leverages USA Technologies’ Platform as a Service to Improve Efficiencies and Cashless Payments Adoption
Empire Vending Leverages USA Technologies’ Platform as a Service to Improve Efficiencies and Cashless Payments Adoption


USA Technologies, Inc. (OTC: USAT) ("USAT"), a cashless payments and software services company that provides end-to-end technology solutions for the self-service retail market, announced that

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference


Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Angela Hwang, Group President, Biopharmaceuticals Group, at the 2nd Annual Wolfe

CORRECTING and REPLACING UBS Advisor Paul D'Aiutolo Named to the Financial Times 401 Top Retirement Plan Advisors List
CORRECTING and REPLACING UBS Advisor Paul D'Aiutolo Named to the Financial Times 401 Top Retirement Plan Advisors List


First paragraph, first sentence of release dated November 11, 2020, should read: UBS announced today that Paul D'Aiutolo, a Financial Advisor in the firm’s Rochester, New York (NY) office has been

RRD Introduces ConnectOne by RRD™, a Comprehensive Platform that Helps Enterprises Optimize Multichannel Marketing & Business Communications
RRD Introduces ConnectOne by RRD™, a Comprehensive Platform that Helps Enterprises Optimize Multichannel Marketing & Business Communications


R.R. Donnelley & Sons Company (RRD) (NYSE:RRD), a leading global provider of marketing and business communications, today unveiled ConnectOne by RRD™, an end-to-end communications management

Wells Fargo Sponsors Panel Discussion on Navigating Uncertainty: Caregiving in a Time of Change
Wells Fargo Sponsors Panel Discussion on Navigating Uncertainty: Caregiving in a Time of Change


Wells Fargo & Company:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201111005252/en/



(Graphic: Wells Fargo)



What:


Wells

Pacific Drilling Commences Solicitation for Prearranged Plan of Reorganization
Pacific Drilling Commences Solicitation for Prearranged Plan of Reorganization


Pacific Drilling S.A. (OTC: PACDQ) announced today that it is commencing solicitation of votes on its proposed prearranged chapter 11 plan of reorganization. On November 10, the United States

Apple AirPlay 2 and HomeKit Support Now Available on Select 4K Roku Streaming Players
Apple AirPlay 2 and HomeKit Support Now Available on Select 4K Roku Streaming Players


Roku, Inc. (NASDAQ: ROKU) today announced, with the release of Roku® OS 9.4, Apple AirPlay 2 and HomeKit support is now available on select 4K Roku devices, including the Roku Ultra, Roku

Great Atlantic Completes Hole One Extends The Jacklyn North Zone By 50 Meter Hit Multiple Intervals of Quartz Veining - Assays Pending Central Newfoundland
Great Atlantic Completes Hole One Extends The Jacklyn North Zone By 50 Meter Hit Multiple Intervals of Quartz Veining - Assays Pending Central Newfoundland

VANCOUVER, British Columbia, November 11th 2020 GREAT ATLANTIC RESOURCES CORP. (TSXV.GR) (the “Company” or “Great Atlantic”) is pleased to announce it has completed the first hole of the

Guidewire InsuranceSuite Positioned as a Leader in the Gartner Magic Quadrant for P&C Core Platforms, North America, for Sixth Consecutive Time: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Guidewire InsuranceSuite Positioned as a Leader in the Gartner Magic Quadrant for P&C Core Platforms, North America, for Sixth Consecutive Time


Guidewire Software, Inc. (NYSE: GWRE), the platform P&C insurers trust to engage, innovate, and grow efficiently, today announced InsuranceSuite has again been recognized as a Leader in the

State Street Expands MediaStats Offering with Central Bank and Thematic Indicators: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24771/405px-State_Street_Corporation_logo.svg.png
State Street Expands MediaStats Offering with Central Bank and Thematic Indicators


State Street Corporation (NYSE:STT) today announced the launch of State Street MediaStats Central Bank Indicators and State Street MediaStats Thematic Indicators - two new quantitative investment

Guidewire InsuranceNow Named a Challenger in the Gartner Magic Quadrant for P&C Core Platforms, North America, for Fourth Consecutive Year: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Guidewire InsuranceNow Named a Challenger in the Gartner Magic Quadrant for P&C Core Platforms, North America, for Fourth Consecutive Year


Guidewire Software, Inc. (NYSE: GWRE), the platform P&C insurers trust to engage, innovate, and grow efficiently, today announced that InsuranceNow has been named to the Challengers quadrant in the

Uranium Energy Corp Applauds Historic Draft Bipartisan Senate Funding Measure for the Formation of a U.S. Uranium Reserve
Uranium Energy Corp Applauds Historic Draft Bipartisan Senate Funding Measure for the Formation of a U.S. Uranium Reserve

Corpus Christi TX, November 11, 2020 - Uranium Energy Corp. (NYSE American: UEC; “UEC” or the “Company”) is pleased to report the Senate Committee on Appropriations has released drafts of

Genprex to Participate in Panel at Life Sciences Summit on November 17
Genprex to Participate in Panel at Life Sciences Summit on November 17


Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced

Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration : https://mms.businesswire.com/media/20191210005404/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg
Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing three novel cell therapies for serious conditions, today announced the successful

Zix Sets November 2020 Financial Conference Schedule
Zix Sets November 2020 Financial Conference Schedule


Zix Corporation (Zix) (NASDAQ: ZIXI), a leading provider of cloud email security, productivity and compliance solutions, is scheduled to participate at the following virtual financial conferences

VictoryShares® Expands Suite of Thematic ETFs: https://mms.businesswire.com/media/20200331005113/en/460034/5/VC_Logo_2c.jpg
VictoryShares® Expands Suite of Thematic ETFs


Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today announced that it has launched the VictoryShares Top Veteran Employers ETF (VTRN) and the VictoryShares

COVID-19 Raises Anxiety Levels for College Students by Presenting Extraordinary Health and Financial Challenges: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23883/AIG_logo.svg.png
COVID-19 Raises Anxiety Levels for College Students by Presenting Extraordinary Health and Financial Challenges


AIG Retirement Services, a leading retirement plan provider for tax-exempt and public sector employers including education institutions, and EVERFI, the nation’s leading social impact education

Havn Life Announces Launch of a Range of Natural Health Products
Havn Life Announces Launch of a Range of Natural Health Products

The 7 initial formulations are designed to support and enhance memory and brain function, the immune system, energy levels, and overall wellness, while reducing the negative impacts of

Novocure Receives CE Mark for NovoTTF-100L™ System: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Receives CE Mark for NovoTTF-100L™ System


Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced that it has received the CE Mark for the NovoTTF-100L

Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting


Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced the presentation of encouraging preliminary results from the ongoing Phase 1/2 study of DCC-3014, a highly selective, oral

CI Financial Enters 12th U.S. RIA Transaction of 2020; Agreement to Acquire US$2.7-Billion Roosevelt Investments Brings Total Projected U.S. Wealth Assets to Approximately US$16.5 Billion: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Financial Enters 12th U.S. RIA Transaction of 2020; Agreement to Acquire US$2.7-Billion Roosevelt Investments Brings Total Projected U.S. Wealth Assets to Approximately US$16.5 Billion


CI Financial Corp. (“CI”) (TSX: CIX) and The Roosevelt Investment Group, Inc. (“Roosevelt”) today announced an agreement under which CI will acquire 100% of Roosevelt, a New York-based registered

Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting


Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced data presentations from clinical studies of QINLOCK, the Company’s switch-control tyrosine kinase inhibitor approved in the U.S. for

More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research
More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research


As the need to improve efficiency and speed in trials grows, more than 75 organizations, including six of the top 20 pharmaceutical companies, are unifying clinical information and processes with

Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimenshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens


Pfizer Inc. (NYSE: PFE) announced today positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral once-daily Janus kinase 1